Loading organizations...

§ Private Profile · London, United Kingdom
Surgery Hero is a technology company.
Surgery Hero operates a digital clinic optimizing the patient surgical journey. It provides personalized programs covering diet, activity, and sleep, alongside one-on-one prehabilitation specialist support. On-demand content and health metric tracking prepare individuals physically, mentally, and emotionally for smoother procedures and efficient recovery. This holistic approach aims to enhance patient preparedness and post-operative outcomes.
Co-founded by Dr. Matthew Beatty, Luke Eastwood, Adam Robinson, and Dr. Robbie Huddleston, the company emerged from the 2020 pandemic's revelation of inadequate surgical preparation. They recognized surgery's parallel to a marathon, requiring extensive readiness for optimal outcomes, spurring a solution for active patient participation. Their insight drives the creation of tools empowering individuals throughout their surgical experience.
Surgery Hero supports employers, health plans, the NHS, and individuals. Its mission is to help 100 million people achieve successful surgeries by empowering patients to control their pathways. The company aims to reduce complications, accelerate recovery, and sometimes avoid surgery, thereby improving overall patient experiences. It envisions fundamentally better surgical care through proactive digital engagement.
Surgery Hero has raised $2.0M across 1 funding round.
Surgery Hero has raised $2.0M in total across 1 funding round.
Surgery Hero is a digital health technology company that builds a platform for perioperative care, combining on-demand content, personalized health coaching, and metrics tracking to prepare patients for surgery and support recovery at home.[1][3][4] It serves employers, health plans, and the UK's National Health Service (NHS), addressing surgery backlogs by reducing hospital stays by an average of 33%, complication rates by 71%, and costs by £946 per elective patient, while boosting patient satisfaction to 8.5/10.[1][3] Formerly Sapien Health, the London-based company founded in 2020 achieved strong NHS adoption across 15 trusts before its acquisition by Sword Health in January 2025, enhancing Sword's AI-driven musculoskeletal care offerings.[1][2][3]
Surgery Hero emerged in 2020 amid NHS elective surgery backlogs, founded by a team including CEO Dr. Matthew Beatty, who led its development as an evidence-based digital platform.[1][3] The idea stemmed from the need to optimize patient preparation and recovery remotely, blending research-backed prehabilitation with technology like personalized plans for diet, activity, sleep, and alcohol moderation.[3][4] Early traction came via the Health Innovation Network's 2021 Digital Health Accelerator, where it refined deployment readiness; pilots at South Tees Hospital NHSFT demonstrated cost savings, paving the way for adoption by 15 NHS trusts serving millions and partnerships with employers.[3] This momentum culminated in its January 2025 acquisition by Sword Health, integrating its team and solution into a global AI Care platform.[1][2]
Surgery Hero rides the wave of digital prehabilitation and AI-augmented healthcare, capitalizing on post-pandemic surgery backlogs, rising chronic pain crises, and NHS pressures in the UK, where limited access to timely care demands scalable solutions.[2][3] Its timing aligns with global shifts toward virtual care—evidenced by Sword Health's expansion, collaborating with 18 NHS trusts for 10 million people—reducing costs (e.g., Sword's $3 saved per $1 invested) amid workforce shortages and elective waitlists.[2][3] By influencing the ecosystem, it sets a model for evidence-based digital tools in perioperative support, now amplifying Sword's mission to digitize musculoskeletal health and free billions from pain through AI-human clinician hybrids.[1][2]
Post-acquisition, Surgery Hero's platform will integrate fully into Sword Health, accelerating UK rollout via NHS partnerships and global employer networks, potentially expanding to full surgical pathways with AI enhancements.[1][2] Trends like AI Care scalability, prehab standardization, and cost-pressured public health systems will propel growth, evolving its influence from niche NHS innovator to core component of comprehensive pain platforms. As Sword targets $650M+ in client savings, Surgery Hero exemplifies how targeted tech resolves systemic bottlenecks, positioning it to redefine perioperative outcomes worldwide.[2]
Surgery Hero has raised $2.0M in total across 1 funding round.
Surgery Hero's investors include Episode 1 Ventures, Clarendon Fund Managers, Crista Galli Ventures, Damien Lane, SFC Capital.
Surgery Hero has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in November 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 1, 2022 | $2M Seed | — | Episode 1 Ventures, Clarendon Fund Managers, Crista Galli Ventures, Damien Lane, SFC Capital | Announced |